What is considered a high CA 19-9 level?

CA 19.9 is above 37 U/mL indicates a cancerous condition, especially of the pancreas CA 19.9 is higher than normal, but less than 75 U/mL ususally indicates infections of the hepatobiliary system and not cancer

Yashoda Hospitals > Diagnostics > CA 19.9 Test

95138 What is the CA 19.9 Test?

CA 19.9, or Carbohydrate Antigen 19.9, is an antigen. An antigen is any substance that elicits your body’s immune system. Carbohydrate antigen (CA) 19.9 is a type of antigen released by pancreatic cancer cells. Such an antigen that tells us about the biological nature of the tumour is called a tumour marker.

CA 19.9 test, also known as the CA 19.9 radio-immunoassay (RIA) test, is a diagnostic test to detect CA 19.9 levels in the blood. This test, however, is not used as a screening test for cancer. That said, some conditions other than cancers can also produce higher levels of CA 19.9.

Book An Appointment at Yashoda hospitals and get a free second opinion.

Book Appointment

Online Video Consultation

Find a Doctor

Health Packages

Need Any Medical Help?

Talk to Our Health Care Experts!

Need Any Medical Help?

Have any Questions?

Why Choose Yashoda Hospitals

Yashoda Hospitals is committed to providing world-class treatment for patients from across the globe. With the unique combination of state-of-the-art technology, intuitive care, and clinical excellence, we are the healthcare destination for thousands of international patients in India.

Comprehensive Care

On the journey to good health, we understand that it is important for you to feel at home. We plan out all aspects of your trip.

Expert Doctors

Experienced specialists perform non-invasive and minimally invasive surgeries to provide the best treatment for international patients.

Cutting-Edge Technology

Our hospitals are equipped with advanced technology to perform a wide range of procedures and treatments.

Clinical Excellence

We deliver excellence by delivering quick and efficient healthcare and through pioneering research that helps all our future.patients.

References

Frequently Asked Questions

The primary use for CA 19.9 test is to serve as a surrogate marker for relapse and prognosis. Based on its levels, the treatment protocol is better understood. A decrease in antigen levels indicates that the treatment is going well; a rise in levels indicates that the tumour has recurred. It can also help distinguish between pancreatic cancer and other diseases of the gland.

If you are at risk for cancer by your doctor or have ongoing cancer treatment, the test may be needed to see how well the treatment is going.

It can be helpful to determine a treatment plan for pancreatic cancer and check whether it has returned. It may be beneficial in some other cancers as well.

In this test, a blood sample is taken from the patient through a vein. It is then sent to a laboratory for testing to find the level of CA 19.9 in the blood. The measurement is done using a radio-immunoassay, or RIA, test. You can expect the results in 24 to 36 hours.

No, there are no prerequisites for the test. However, let your physician know about all the medicines, herbal remedies, vitamins, and supplements you are taking, including any medications not requiring a prescription or any other substances you might use or abuse.

Like any other blood test with a needle, this too has certain risks such as bleeding, infection, bruising, and lightheadedness. The sensation of pain may be felt when the needle pricks the arm or the hand. Afterward, the site may be sore.

The results are given in units per millilitre (U/mL).

Normal results range from 0-37 U/mL. It's important to understand that higher levels of CA 19-9 may not automatically mean that you have cancer.

CA 19.9 is above 37 U/mL indicates a cancerous condition, especially of the pancreas
CA 19.9 is higher than normal, but less than 75 U/mL ususally indicates infections of the hepatobiliary system and not cancer

According to research, a patient's CA 19-9 level decreases after resection. CA 19-9 levels fluctuate without significant clinical symptoms upon receiving chemotherapy. The levels may increase if cancer has recurred.

CA 19.9 is raised in any of the following conditions -